Laman Utama300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Tutup sebelumnya
¥18.50
Julat hari
¥18.29 - ¥18.62
Julat tahun
¥12.93 - ¥34.18
Permodalan pasaran
20.42B CNY
Bilangan Purata
18.87J
Nisbah P/E
40.78
Hasil dividen
2.06%
Pertukaran utama
SHE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 816.14J | 11.21% |
Perbelanjaan pengendalian | 441.56J | 6.14% |
Pendapatan bersih | 185.76J | -0.46% |
Margin untung bersih | 22.76 | -10.50% |
Pendapatan bagi setiap syer | 0.16 | -2.13% |
EBITDA | 348.52J | 22.34% |
Kadar cukai berkesan | 6.09% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 310.71J | -70.41% |
Jumlah aset | 14.52B | -1.41% |
Jumlah liabiliti | 4.81B | -6.59% |
Jumlah ekuiti | 9.71B | — |
Syer tertunggak | 1.12B | — |
Harga kepada buku | 2.13 | — |
Pulangan pada aset | 5.17% | — |
Pulangan pada modal | 6.38% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 185.76J | -0.46% |
Tunai daripada operasi | 178.68J | -37.64% |
Tunai daripada pelaburan | -262.60J | -774.60% |
Tunai daripada pembiayaan | -42.46J | -25,008.80% |
Perubahan bersih dalam tunai | -126.53J | -149.37% |
Aliran tunai bebas | -1.95B | -214.48% |
Perihal
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Diasaskan
8 Sep 1992
Tapak web
Pekerja
1,902
